Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Teva's Fourth-Quarter Adjusted Earnings Top Forecasts
By Dan Weil
Feb 10, 2021 8:41 AM EST
PRESS RELEASES
Teva To Present At The J.P. Morgan 2021 Global High Yield And Leveraged Finance Conference
By Business Wire
Mar 1, 2021 4:00 PM EST
PRESS RELEASES
New Study Published In Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine Treatments
By Business Wire
Feb 26, 2021 8:00 AM EST
INVESTING
Teva's Fourth-Quarter Adjusted Earnings Top Forecasts
By Dan Weil
Feb 10, 2021 8:41 AM EST
PRESS RELEASES
Teva To Host Conference Call To Discuss Fourth Quarter 2020 Financial Results And 2021 Financial Guidance At 8 A.m. ET On February 10, 2021
By Business Wire
Jan 8, 2021 3:01 PM EST
PRESS RELEASES
Teva To Present At The 39th Annual J.P. Morgan Healthcare Conference
By Business Wire
Jan 7, 2021 4:00 PM EST
PRESS RELEASES
Teva And MedinCell Announce Positive Results For Registration Trial Of Investigational Extended-Release Subcutaneous Injectable Risperidone For Patients With Schizophrenia
By Business Wire
Jan 7, 2021 8:00 AM EST
PRESS RELEASES
DEADLINE TODAY: The Schall Law Firm Announces It Is Investigating Claims Against Teva Pharmaceuticals Industries Limited And Encourages Investors With Losses Of $100,000 To Contact The Firm
By Business Wire
Nov 23, 2020 8:52 AM EST
INVESTING
Teva 3rd-Quarter Adjusted Profit Meets Estimate; Revenue Lags
By Tony Owusu
Nov 5, 2020 9:23 AM EST
PRESS RELEASES
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Teva Pharmaceuticals Industries Limited Of Class Action Lawsuit And Upcoming Deadline - TEVA
By PR Newswire
Oct 31, 2020 11:27 PM EDT
PRESS RELEASES
ROSEN, A LEADING LAW FIRM, Reminds Teva Pharmaceuticals Industries Limited Investors Of The Important Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $500K To Contact The Firm - TEVA
By PR Newswire
Oct 30, 2020 8:40 PM EDT
PRESS RELEASES
Teva, Amazon Web Services And Onica Announce Collaboration To Support Teva's Digihaler® Portfolio
By Business Wire
Oct 21, 2020 8:00 AM EDT
JIM CRAMER
Magnificent Seven: Cramer's 'Mad Money' Recap (Monday 10/19/20)
By Scott Rutt
Oct 19, 2020 9:39 PM EDT
PRESS RELEASES
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Teva Pharmaceuticals Industries Limited Of Class Action Lawsuit And Upcoming Deadline - TEVA
By PR Newswire
Oct 17, 2020 6:40 PM EDT
PRESS RELEASES
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors Of The Important Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $500K To Contact The Firm - TEVA
By PR Newswire
Oct 15, 2020 5:45 PM EDT
PRESS RELEASES
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors Of The Important November 23 Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - TEVA
By Business Wire
Oct 5, 2020 5:40 PM EDT
PRESS RELEASES
Teva Canada Announces Availability Of Aermony RespiClick™ (fluticasone Propionate Inhalation Powder), An Innovative New Device For The Treatment Of Bronchial Asthma
By Business Wire
Oct 5, 2020 8:00 AM EDT
PRESS RELEASES
INVESTOR ALERT: Law Offices Of Howard G. Smith Announces Investigation Of Teva Pharmaceutical Industrial Limited (TEVA) On Behalf Of Investors
By Business Wire
Oct 1, 2020 12:00 PM EDT
PRESS RELEASES
Teva To Host Conference Call To Discuss Third Quarter 2020 Financial Results At 8 A.m. ET On November 5, 2020
By Business Wire
Oct 1, 2020 11:06 AM EDT
PRESS RELEASES
Glancy Prongay & Murray LLP, A Leading Securities Fraud Law Firm, Announces Investigation Of Teva Pharmaceutical Industrial Limited (TEVA) On Behalf Of Investors
By Business Wire
Sep 30, 2020 8:06 PM EDT
PRESS RELEASES
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm
By Business Wire
Sep 28, 2020 8:45 AM EDT
PRESS RELEASES
ROSEN, LEADING INVESTOR COUNSEL, Announces Filing Of Securities Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - TEVA
By PR Newswire
Sep 25, 2020 6:58 PM EDT
PRESS RELEASES
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm
By Business Wire
Sep 24, 2020 5:22 PM EDT
PRESS RELEASES
TEVA EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited - TEVA
By Business Wire
Sep 24, 2020 3:06 PM EDT
PRESS RELEASES
Pomerantz Law Firm Announces The Filing Of A Class Action Against Teva Pharmaceuticals Industries Limited And Certain Officers - TEVA
By PR Newswire
Sep 23, 2020 8:20 PM EDT
